Pharmaceutical Testing and Analytical Services Market: Companies Expand Portfolio in Release Testing of Innovative Products and Microbiology

Pharmaceutical Testing and Analytical Services Market: Introduction

According to the report, the global pharmaceutical testing and analytical services market was valued at US$ 3.5 Bn in 2019. It is projected to expand at a CAGR of ~11% from 2020 to 2030. Pharmaceutical testing and quality assurance are important stages in the pharmaceutical industry. Testing and analysis are carried out as people’s lives depend on the quality and quantity measure of a given medicine. Bioanalytical testing, method development & validation, raw material testing, stability testing, and microbial testing are commonly employed tests adopted in pharmaceutical and medical devices industries. The expansion of the global pharmaceutical testing and analytical services market can be ascribed to rise in the number of clinical trials and increase in R&D spending.

North America dominated the global pharmaceutical testing and analytical services market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players who are focused on design and development of new treatment options for the treatment of major chronic diseases is likely to further drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global pharmaceutical testing and analytical services market. It is projected to expand at a rapid pace during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55191

Rise in Number of Clinical Trials and Increase in R&D Spending to Drive Global Market

The increase in the number of clinical trials is projected to boost the pharmaceutical testing and analytical services market. Rising prevalence of cancer is a key factor driving the number of clinical trials being conducted. Furthermore, it is estimated that the number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. Increase in R&D spending and focus of biopharmaceutical companies on boosting revenues has propelled the pharmaceutical testing and analytical services market.

Inorganic growth is a key strategy adopted by major players operating in the pharmaceutical testing and analytical services market in order to consolidate their position in the market. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market. These factors are estimated to propel the pharmaceutical testing and analytical services market during the forecast period.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=55191

Bioanalytical Testing Segment to Dominate Global Market

Based on service type, the global pharmaceutical testing and analytical services market has been divided into bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further segmented into cell-based assays, virology testing, and others. The method development & validation segment has been sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. The raw material testing segment has been split into heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others. The bioanalytical testing segment dominated the global pharmaceutical testing and analytical services market in 2019. This trend is projected to continue during the forecast period.

The increase in use of cell-based assay, virology, and other tests in drug development is likely boost the bioanalytical testing segment during the forecast period. Cell-based assays have been a key component in streamlining the drug development process, helping drugs to be introduced in the market in a rapid and efficient manner.

The method development & validation segment was followed by the bioanalytical testing segment, in terms of market share, in 2019.

Request for Analysis of COVID-19 Impact on Pharmaceutical Testing and Analytical Services Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55191

Pharmaceutical & Biopharmaceutical Companies to Offer Lucrative Opportunities

In terms of end user, the global pharmaceutical testing and analytical services market has been split into medical device companies, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical companies segment accounted for a prominent share of the global pharmaceutical testing and analytical services market in 2019. The expansion of the segment can be attributed to a surge in focus of biopharmaceutical companies on expansion, shifting fixed costs to variable costs, and incorporation of technological advances in their research process, which is highly cost intensive. These factors are fueling the outsourcing of the research & development process, thereby boosting the segment.

North America to Dominate Global Pharmaceutical Testing and Analytical Services Market

The global pharmaceutical testing and analytical services market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pharmaceutical testing and analytical services market in 2019. It was followed by Europe. The U.S. dominated the market in North America, owing to the presence of major market players, significant healthcare expenditure, and increase in research activities across the region. Robust expansion of the market in the region can be attributed to increase in the number of clinical trials and a rise in the demand for biosimilars owing to patent expiry, which fuels the demand for rapid conduction of trials and regulatory approvals. This, in turn, fuels the demand for analytical testing from pharmaceutical manufacturers and consequently boosts the market.

The pharmaceutical testing and analytical services market in Asia Pacific is anticipated to expand at a rapid rate from 2020 to 2030.

Buy Pharmaceutical Testing and Analytical Services Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=55191&ltype=S

Competition Landscape of Pharmaceutical Testing and Analytical Services Market

The global pharmaceutical testing and analytical services market is fragmented in terms of number of players. Key players operating in the global market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc, RD Laboratories, Inc., WuXi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Back to news